Medindia
Medindia LOGIN REGISTER
Advertisement

Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System

Saturday, January 9, 2010 General News
Advertisement
Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms

CONTACTS:

                Paul Donovan

                Media Relations

                Boston Scientific Corporation

                508-650-8541 (office)

                508-667-5165 (mobile)

                Larry Neumann

                Investor Relations

                Boston Scientific Corporation

                508-650-8696 (office)

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close